Outset Medical (NASDAQ:OM – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk and earnings.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Outset Medical and KORU Medical Systems, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Outset Medical | 1 | 1 | 2 | 1 | 2.60 |
| KORU Medical Systems | 1 | 1 | 3 | 1 | 2.67 |
Outset Medical presently has a consensus target price of $10.67, suggesting a potential upside of 137.04%. KORU Medical Systems has a consensus target price of $6.13, suggesting a potential upside of 24.49%. Given Outset Medical’s higher probable upside, equities research analysts clearly believe Outset Medical is more favorable than KORU Medical Systems.
Insider and Institutional Ownership
Volatility and Risk
Outset Medical has a beta of 2.08, indicating that its share price is 108% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.
Earnings & Valuation
This table compares Outset Medical and KORU Medical Systems”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Outset Medical | $113.69 million | 0.72 | -$127.98 million | ($13.05) | -0.34 |
| KORU Medical Systems | $33.65 million | 6.77 | -$6.07 million | ($0.08) | -61.50 |
KORU Medical Systems has lower revenue, but higher earnings than Outset Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Outset Medical and KORU Medical Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Outset Medical | -73.12% | -71.37% | -30.11% |
| KORU Medical Systems | -9.49% | -22.43% | -13.86% |
Summary
KORU Medical Systems beats Outset Medical on 10 of the 14 factors compared between the two stocks.
About Outset Medical
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.
